Treatment
Cannabidiol (CBD) clinical trials
We’re tracking 34 recruiting studies that include Cannabidiol (CBD), each written for real people, not researchers, below.
Recruiting studies
- NCT06686914RecruitingPhase 1
How CBD affects driving by dose and sex
This study tests how different doses of CBD (a cannabis compound) affect driving ability in healthy adults. It looks at whether men and women react differently, and helps understand if CBD is safe to use before driving.
Morgantown, West VirginiaAges 18–30 - NCT07279558RecruitingPhase 2
CBD and Alcohol Use Study
This study tests whether cannabidiol (CBD), a compound from cannabis, can help people who drink alcohol regularly reduce their drinking or change their drinking patterns. You may be eligible if you're 21-65, have used CBD or cannabis before, drink alcohol regularly, and don't take certain medications that could interfere.
Aurora, ColoradoAges 21–65 - NCT07069478Recruiting
CBD and stress response study
This study looks at how cannabidiol (CBD) affects your body's response to stress. You may be able to help researchers understand if regular CBD use changes how you handle stressful situations.
Minneapolis, MinnesotaAges 21–70 - NCT05020028RecruitingPhase 2/Phase 3
CBD to reduce knee pain from osteoarthritis
This study tests cannabidiol (CBD) to help lower pain from knee osteoarthritis. It may be an option if you have ongoing knee pain and meet age, safety, and medication guidelines.
New York, New YorkAges 40–75 - NCT07167446RecruitingEarly Phase 1
CBD to prevent nerve damage from oxaliplatin in colorectal cancer
This trial tests if cannabidiol (CBD) can prevent nerve damage (neuropathy) caused by the chemotherapy drug oxaliplatin. If you have colorectal cancer that has spread or cannot be removed by surgery and you are about to start oxaliplatin, you may be able to join.
Philadelphia, PennsylvaniaAges 18 years+ - NCT05269628RecruitingPhase 2
Cannabidiol for multiple sclerosis sleep and pain patterns
This study looks at whether cannabidiol (CBD, a cannabis-related medicine) can improve symptoms in people with multiple sclerosis (MS), especially how sleep and pain type affect outcomes. It’s mainly for people with MS and ongoing moderate-to-severe pain, while carefully checking safety and medication interactions.
Ann Arbor, MichiganAges 18–65 - NCT06213233RecruitingPhase 2
CBD oil for veterans with chronic pain
This study tests whether CBD oil can help veterans manage chronic pain. You would take a daily dose of CBD and report your symptoms using a smartphone app.
Ann Arbor, MichiganAges 18 years+ - NCT06414473RecruitingPhase 1/Phase 2
CBD for knee osteoarthritis pain
This study tests whether a CBD (cannabidiol) product can help reduce pain and improve daily life for people with knee osteoarthritis. If you have moderate to severe knee pain and haven't used cannabis recently, you may be able to join.
Gainesville, FloridaAges 40–75 - NCT07298408RecruitingPhase 1/Phase 2
CBD for Diabetic Nerve Pain: A Pilot Study
This trial tests whether a daily dose of CBD (a cannabis compound) can help reduce nerve pain from type 2 diabetes. It's a small, early study to see if it's safe and effective.
Tallahassee, FloridaAges 40–70 - NCT05015439RecruitingPhase 1
CBD study for adults with autism and challenging symptoms
This Phase 1 study tests cannabidiol (CBD) in adults on the autism spectrum who also have mood, sleep, or behavior problems. The goal is to learn whether CBD can be given safely and may help symptoms that affect daily life.
Baltimore, MarylandAges 18 years+ - NCT05269459RecruitingPhase 2
CBD for PTSD symptoms in adults
This Phase 2 study tests whether cannabidiol (CBD) can safely reduce PTSD symptoms in adults. You may be eligible if you have a current PTSD diagnosis and can follow the study steps for the full time.
Omaha, NebraskaAges 21–65 - NCT05867849RecruitingPhase 3
Cannabidiol treatment for bipolar depression symptoms
This trial tests whether cannabidiol (CBD) can reduce symptoms of bipolar depression. You may be eligible if you have bipolar I or II and a current depressive episode while staying on approved mood-stabilizing or antipsychotic medication.
Vancouver, British ColumbiaAges 19–70 - NCT06542445RecruitingPhase 2
CBD oil study for children with ADHD
This study tests if a CBD oil enriched with terpenes can help reduce ADHD symptoms in children and teens. It may offer an alternative to standard ADHD medications.
ẔerifinAges 6–18 - NCT07668856RecruitingPhase 3
CBD for children with hard-to-treat epilepsy
This trial tests if adding cannabidiol (CBD) to your child's current seizure medicines can reduce seizures. It uses a personalized approach to see if CBD works for each child.
Utrecht, UtrechtAges 1–18 - NCT06994520Enrolling by invitationPhase 2
Topical cannabis extract for eczema itch
This study tests a cannabis-based cream on eczema-related itch over 4 weeks. It may help reduce itching if other treatments haven't worked, but requires pausing other skin products during the trial.
Khon Kaen, Changwat Khon KaenAges 25 years+ - NCT04411225RecruitingPhase 3
CBD may help early psychosis along with usual treatment
This Phase 3 trial tests whether taking cannabidiol (CBD) can reduce symptoms when added to standard care for early psychosis (like first-episode psychosis or attenuated psychosis). It may help some people have fewer troubling thoughts or perceptions over time.
La Jolla, CaliforniaAges 16–30 - NCT06218056RecruitingPhase 2
CBD for reducing cigarette smoking in a treatment center
This study tests whether a daily dose of cannabidiol (CBD) can help people who smoke at least 5 cigarettes a day cut down or quit. It is for people staying at a treatment center in Los Angeles where cannabis use is not allowed.
North Hollywood, CaliforniaAges 18–65 - NCT04883255RecruitingEarly Phase 1
Study cannabis effects on brain function in adults with HIV
This early-phase study looks at how cannabis (and the body’s cannabinoid system) may affect thinking and brain-related measures in people with HIV. You may be asked to avoid cannabis and complete several brain and health assessments to see how these factors relate.
San Diego, CaliforniaAges 18–65 - NCT04992624RecruitingPhase 2
Cannabinoid treatment effects on knee pain and nerve signals
This Phase 2 study tests whether a cannabinoid-related treatment changes how pain works in people with knee osteoarthritis. It uses questionnaires, MRI, and gentle nerve testing to understand if treatment helps pain and pain-related signals.
Ann Arbor, MichiganAges 21–75 - NCT07233239RecruitingPhase 1
CBD liquid for focal epilepsy seizures
This trial tests a new cannabidiol (CBD) liquid medicine for people with focal epilepsy (seizures that start in one part of the brain). It looks at whether the medication can help reduce seizures when added to your current seizure medications.
Phoenix, ArizonaAges 12–75 - NCT04587791RecruitingEarly Phase 1
Cannabidiol (CBD) for opioid use disorder and chronic pain
This early study tests whether CBD can reduce symptoms of chronic pain in people receiving opioid maintenance treatment for opioid use disorder. It also looks at safety and whether CBD can be added without causing major problems.
West Haven, ConnecticutAges 18–70 - NCT07001930RecruitingPhase 1
Cannabidiol effects on stress and nicotine withdrawal
This trial tests whether a cannabis-derived compound called cannabidiol (CBD) can help people who smoke cigarettes cope with stress and withdrawal symptoms when they stop smoking. CBD is not the part of cannabis that makes you high.
Baltimore, MarylandAges 21–70 - NCT06014424RecruitingPhase 2
CBD medication study for agitation in Alzheimer's
This study tests if a CBD medication can help reduce agitation in people with Alzheimer's disease. It's for adults 55 and older who have significant agitation and mild to moderate dementia.
Calgary, AlbertaAges 55 years+ - NCT06574100RecruitingPhase 1
CBD Pill Study for Healthy Men
This study tests how two different CBD pills are absorbed by the body. It is for healthy men aged 18-35 and involves two one-day clinic visits with blood draws.
Saskatoon, SaskatchewanAges 18–35
What Cannabidiol (CBD) is being studied for
Conditions with recruiting Cannabidiol (CBD) studies.
Common questions
- Are there clinical trials studying Cannabidiol (CBD)?
- Yes. Clin2 currently lists 34 recruiting studies that include Cannabidiol (CBD), drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Cannabidiol (CBD) trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Cannabidiol (CBD) an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Cannabidiol (CBD) or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.